Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Form of Underwriting Agreement
- 5.1 Opinion of Lowenstein Sandler LLP Regarding the Validity of the Common Stock Being Registered
- 10.16 Agreement for Rendering of Research Services Between Lipocurerx, LTD. and Virpax Pharmaceuticals, Inc., Dated June 29, 2021
- 10.23 Agreement for Rendering of Research Services Between Virpax Pharmaceuticals, Inc. and Yissum Research Development Company of the Hebrew University of Jerusalem, LTD., Dated June 30, 2021
- 23.1 Consent of Eisneramperllp, Independent Registered Public Accounting Firm for the Financial Statements of Virpax Pharmaceuticals, Inc.**
- Download Excel data file
- View Excel data file
Associated filings
VRPX similar filings
Filing view
External links
Exhibit 23.1
We consent to the inclusion in this Registration Statement of Virpax Pharmaceuticals, Inc. on Form S-1 to be filed on or about September 9, 2021 of our report dated March 31, 2021, on our audits of the financial statements as of December 31, 2020 and 2019 and for each of the years then ended. We also consent to the reference to our firm under the caption “Experts” in this Registration Statement.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Philadelphia, Pennsylvania
September 9, 2021